ST.27-legal status data

The legal status information displayed below is based on WIPO Standard ST.27 and of a purely informative nature. Binding information on the status of the IP right is only available in DPMAregister (Show details).

DE file number: 60 2020 020 417.2, EP file number: 20 80 7558.0, WO file number: PCT/US2020/056408 (Designation/title: VERFAHREN ZUR BEHANDLUNG HÄMATOLOGISCHER MALIGNOME MIT 2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)METHYL)BENZ YL)AMINO)ISOINDOLINE-1,3-DION)

↩ Details

Tabular representation
Current state: Active, Current state: Grant

Key event history
No. Key Event Code Key Event Name Event Date Effective Date Effective Date sorted ascending Publication Date To Stage
1 Q10 Document published Apr 29, 2021Apr 29, 2021 unchanged
2 Q10 Document published Aug 31, 2022Aug 31, 2022 Filing
3 Q10 Document published Oct 13, 2022Oct 13, 2022Oct 13, 2022 Filing
4 Q10 Document published Nov 1, 2023Nov 1, 2023 Examination
5 Q10 Document published Nov 16, 2023Nov 16, 2023Nov 16, 2023 Examination
6 F10 IP right granted Aug 2, 2024Aug 2, 2024Oct 24, 2024 Grant
Detailed event history
No. Detailed Event Code Detailed Event Name Event Date Effective Date Effective Date sorted ascending Publication Date To Stage
1 Q12 Application published Apr 29, 2021Apr 29, 2021 unchanged
2 Q12 Application published Aug 31, 2022Aug 31, 2022 Filing
3 Q10 Document published Oct 13, 2022Oct 13, 2022Oct 13, 2022 Filing
4 Q10 Document published Nov 1, 2023Nov 1, 2023 Examination
5 Q10 Document published Nov 16, 2023Nov 16, 2023Nov 16, 2023 Examination
6 F10 IP right granted Aug 2, 2024Aug 2, 2024Oct 24, 2024 Grant

Graphical representation

Below you will see a simplified graphical representation of the legal status information, which is based on WIPO Standard ST.27 using the "Overall Patent/SPC Prosecution Model" defined therein.

Graphical representation of the ST.27 legal status data